Immunological Basis of Gastrointestinal Disorders - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Immunological Basis of Gastrointestinal Disorders

Description:

Immunological Basis of Gastrointestinal Disorders The immune System The cells and molecules responsible for immunity ... – PowerPoint PPT presentation

Number of Views:77
Avg rating:3.0/5.0
Slides: 43
Provided by: clinimmso
Learn more at: https://clinimmsoc.org
Category:

less

Transcript and Presenter's Notes

Title: Immunological Basis of Gastrointestinal Disorders


1
??? ???? ?????? ??????
2
Immunological Basis of Gastrointestinal
Disorders
Maha A. El Bassuoni Ass.Prof. of Clinical
Pathology Faculty of Medicine , Menoufiya
University, EGYPT
3
The immune System
  • The cells and molecules responsible for immunity
    constitute the immune system.
  • The immune system has to be able to respond to
    protect the human body from a very large number
    of foreign antigens introduced at any site.

4
Mucosal Immune System
  • The mucosal immune system is recognized by
    differences from its systemic counterpart.
  • It is recognized that the mucosal immune
    response is also distinct, largely focused on
    suppressing immunity rather than promoting it.

5
(No Transcript)
6
Gut Associated Lymphoid Tissue(GALT)
7
Structure of Secretory IgA
  • It consists of at least two IgA molecules
    covalently linked by a J chain and the secretory
    component, which is added as the antibody crossed
    the mucosal epithelial cells into the lumen.

8
Gastrointestinal Organs Disorders
  • Gastrointestinal Disorders
  • Pancreatic Disorders
  • Hepatobiliary Disorders
  • Orodental Disorders

9
A. Gastrointestinal Disorders1. Food -Induced
Gastrointestinal DisordersI. Gluten-sensitive
Enteropathy Celiac Disease
10

A. Gastrointestinal Disorders1. Food -Induced
Gastrointestinal DisordersI. Gluten-sensitive
Enteropathy Celiac Disease
  • Laboratory Investigation
  • Hypoalbuminemia hypoproteinemia
  • Iron, folate, and, vB12 deficiency.
  • PT prolonged
  • circulating IgA and IgG to gliadin
  • IgA antibody to endomysium has higher sensitivity
    and specificity
  • Endomysial antibodies on smooth muscle

11
A. Gastrointestinal Disorders1. Food -Induced
Gastrointestinal Disorders II. Gastrointestinal
food allergy diseases
  • Allergy is an immunological phenomena
  • refers to certain diseases in which immune
    responses to environmental antigens causes tissue
    inflammation and organ dysfunction.
  • Hypersensitivity and Sensitivity used as synonyms
    for allergy.

12
A. Gastrointestinal Disorders1. Food -Induced
Gastrointestinal Disorders II. Gastrointestinal
food allergy diseases
  • a. Dietary Protein-Induced Proctitis/Proctocolitis
  • eosinophilic infiltration and occasionally
    lymph-nodular hyperplasia.
  • b. Dietary Protein Enteropathy
  • T cell responses
  • c. Dietary Protein Enterocolitis milk-specific T
    cell response
  • d. Immediate Gastrointestinal Hypersensitivity
  • mediated by IgE antibody
  • e. Eosinophilic Gastroenteropathies
  • both cell-mediated and IgE antibody-mediated

13
d. Immediate Gastrointestinal Hypersensitivity
II. Gastrointestinal food allergy diseases
  • Allergy testing
  • In vitro tests
  • Tests for IgE Abs (RAST).
  • Tests for IgG Abs .
  • Tests for Immune complex.
  • Tests for Lymphocyte stimulation
  • Antigen cross links IgE on mast cells in tissues
    Mast Cell Degranulation

14
A. Gastrointestinal Disorders2. Chronic Atrophic
Gastritis
  • Normal Atrophic

15
A. Gastrointestinal Disordes 2. Chronic Atrophic
Gastritis Autoimmune Atrophic Gastritis
(Type A)
16
A. Gastrointestinal Disordes 2. Chronic Atrophic
Gastritis Autoimmune Atrophic Gastritis
Types of intrinsic factor antibodies
17
A. Gastrointestinal Disordes 2. Chronic
Atrophic Gastritis Autoimmune Atrophic
Gastritis
  • Anti-Parietal Cells (Rat stomach)
  • Diagnosis of autoimmune gastritis however, it can
    be ascertained histologically
  • (1) Antiparietal and anti-IF antibodies in the
    serum.
  • (2) Achlorhydria and hypergastrinemia
  • (3) serum v. B12 levels, usually low.

18
A. Gastrointestinal Disordes 2. Chronic
Atrophic Gastritis Gastric autoantibodies
19
A. Gastrointestinal Disorders 3.Human
immunodeficiency Virus Enteropathy
  • HIV infection
  • HIV is one of the group of viruses known as
    retroviruses.
  • When HIV infects a human cell, its RNA has to be
    converted to DNA.
  • It exerts its effect both directly, through
    infection of the intestinal cells and indirectly
    through impairment of the intestinal immune
    response.
  • The antigenicity of various components provides a
    means for detection of antibody, and the basis
    for most HIV testing.

20
HIV Virus Lifecycle
21
Gastrointestinal Disorders 4.Whipple's Disease
  • Diagnosis
  • microscopic examination of specimens. The
    established cultivation of the bacterium and the
    isolation from infected intestinal biopsies
  • PCR analysis, which has high sensitivity and
    specificity.

22
A. Gastrointestinal Disorders 5. Inflammatory
Bowel Diseases I. Crohn's Disease
II. Ulcerative colitis
23
A. Gastrointestinal Disorders 5. Inflammatory
Bowel Diseases

24
A. Gastrointestinal Disorders 5. Inflammatory
Bowel Diseases I. Crohn's Disease
II. Ulcerative colitis
25
A. Gastrointestinal Disorders 5. Inflammatory
Bowel Diseases I. Crohn's Disease
II. Ulcerative colitis
  • Based on the cytotoxicity findings Sauberman et
    al. postulate that in mice the stimulation of NKT
    cells through antigen presented to these cells by
    CD1d-bearing DCs or epithelial cells (MHC
    class1-like).
  • The stimulated NKT cells, then begin to produce
    IL-13, they become capable of lysing epithelial
    cells, leads to epithelial cell loss and
    ulceration.
  • Enteric bacterial flora has been reported in both
    animal models and IBD patients.
  • In animal models Oslon et al have reported that
    CD4CD45RBloCD25 regulatory T cells (Treg cells)
    prevent colitis induced by transferring effector
    CD4CD45RBhiCD25 T cells into SCID mice through
    mechanisms involving TGF-ß and IL-10.

26
B. Pancreatic Disorders
  • Laboratory tests
  • ? serum amylase and lipase only during acute
    attacks of pancreatitis, usually early in the
    course of the disease.
  • ? concentrations of serum trypsin are relatively
    specific for advanced chronic pancreatitis. (not
    sensitive enough)
  • ANA test
  • Fecal tests (Steatorrhea a manifestation of
    advanced disease)
  • Pancreatic function tests
  • Autoimmune pancreatitis is uncommon and accounts
    for less than 1 of cases of chronic
    pancreatitis.
  • local expression and release of TGF-ß, enhances
    synthesis of extracellular matrix proteins,
    (collagens, fibronectin).
  • MCP-1mRNA IL8 and ENA mRNA in centroacinar
    ducts.

27
C. HEPATOBILIARY DISORDERS
  • 1. LIVER DISORDERS
  • Viral Hepatitis
  • Autoimmune Hepatitis
  • 2. BILIARY DISORDERS
  • Primary Biliary Cirrhosis (PBC)
  • Primary Sclerosing Cholangitis (PSC)

28
C. HEPATOBILIARY DISORDERS1. LIVER DISORDERS I.
Viral Hepatitis HAV HEV
Acute HEV infection Pregnant female in 3rd
trimester 25 risk of mortality
Epidemics by contaminated water or food suorce
29
C. HEPATOBILIARY DISORDERS1. LIVER DISORDERS
I. Viral Hepatitis HBV HDV
Progress to cirrhosis
Flare of HBV and FHF
30
C. HEPATOBILIARY DISORDERS1. LIVER DISORDERS
I. Viral Hepatitis HCV
85 chronic cases Associated with autoimmune
hepatitis
31
C. HEPATOBILIARY DISORDERS1. LIVER DISORDERS
II. Autoimmune Hepatitis
32
C. HEPATOBILIARY DISORDERS1. LIVER DISORDERS
II. Autoimmune Hepatitis
Laboratory diagnosis
Anti SLA
  • Autoantibodies Autoimmune hepatitis type 1 is
    characterized by positive ASMA and ANA.
  • Type 2 marked by a positive antiLKM-1 antibody.
  • Type 3 is marked by a positive anti-SLA antibody.
  • Anti-actin

33
C. HEPATOBILIARY DISORDERS1. LIVER DISORDERS
II. Autoimmune Hepatitis
  • Laboratory Diagnosis
  • Hypergammaglobulinemia
  • ?AST and ALT
  • ?S. bilirubin and ALP
  • Hypoalbuminemia and prolongation of PT
  • Other common laboratory abnormalities
  • mild leucopenia
  • Normochromic anemia
  • Coombs-positive hemolytic anemia
  • Thrombocytopenia

34
C. HEPATOBILIARY DISORDERS2. BILIARY DISORDERS
35
C. HEPATOBILIARY DISORDERS2. BILIARY DISORDERS
I. Primary Biliary Cirrhosis
36
C. HEPATOBILIARY DISORDERS2. BILIARY DISORDERS
I. Primary Biliary Cirrhosis
  • The hallmark of the disease is the presence of
    AMAs in the sera.
  • AMAs found in 90-95 of patients and have a
    specificity of 98.
  • Elevation of
  • ALT
  • AST
  • ALP
  • GGTP.
  • Lipid levels (HDL) and cholesterol levels may be
    increased .
  • Elevated bilirubin level
  • Prolonged PT
  • Decreased albumin level

AMA
37
C. HEPATOBILIARY DISORDERS2. BILIARY DISORDERS
II. Primary Sclerosing Cholangitis
38
C. HEPATOBILIARY DISORDERS2. BILIARY DISORDERS
II. Primary Sclerosing Cholangitis
  • Laboratory Diagnosis
  • Increased ALP and total bilirubin,
  • Increased transaminases
  • Hypergammaglobulinemia,
  • P-ANCA (65-85 of cases)
  • ANA, (ASMA), anti-cardiolipin autoantibodies
  • Anti-mitochondrial autoantibodies (AMA) are
    negative
  • P-ANCA

39
D. ORODENTAL DISORDERS
  • 1. Inflammatory Periodontal Diseases
  • Gingivitis and periodentitis
  • polymorph induced damage, complement induced
    damage (through IgG (IgG2). peripheral T cell
    reactivity to plaque antigens
  • Juvenile Periodontitis defects in granulocyte or
    monocyte function conventional.

40
D. ORODENTAL DISORDERS
  • 2. Recurrent Aphthous Ulceration
  • Raised level of circulating antibody to saline
    extract of fetal oral mucous membrane.
  • These antibodies may be a response to exposed
    tissue antigen that previously been protected
    from immune system. (Ag against oral mucous
    membrane, epithelial cells. or viral Ags).
  • CMI proved by an infiltrate of lymphocyte

41
D. ORODENTAL DISORDERS
  • 3.Oral Candidiasis
  • A threshold number of systemic CD4 cells to
    protect the oral mucosa together with the status
    of local immunity.
  • HIV infected persons with and without OPC had a
    Th2-type salivary cytokine profile suggestive of
    susceptibility to Candida infection
  • GM-CSF are important in the generation of
    effective immunity to C. albicans. .
  • 4. Oral Hairy Leukoplakia
  • There is correlation of diminished CD4 T
    lymphocyte count to the occurrence of the
    lesions.

42
Thank You
Write a Comment
User Comments (0)
About PowerShow.com